Kuangli Bio-Tech Holdings Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was TWD 342.16 million compared to TWD 332.63 million a year ago. Net loss was TWD 68.72 million compared to net income of TWD 25.84 million a year ago.

Basic loss per share from continuing operations was TWD 1.22 compared to basic earnings per share from continuing operations of TWD 0.88 a year ago. Diluted loss per share from continuing operations was TWD 1.22 compared to diluted earnings per share from continuing operations of TWD 0.88 a year ago. Basic loss per share was TWD 1.22 compared to basic earnings per share of TWD 0.51 a year ago.

Diluted loss per share was TWD 1.22 compared to diluted earnings per share of TWD 0.51 a year ago.